We are live on ! Find out more
CAM

Covenant Asset Management Portfolio holdings

AUM $595M
1-Year Est. Return 38.14%
This Fund
S&P 500
This Quarter Est. Return
+13.83%
1 Year Est. Return
+38.14%
3 Year Est. Return
+158.45%
5 Year Est. Return
+212.83%
10 Year Est. Return
AUM
$336M
AUM Growth
+$15.3M
Cap. Flow
-$20.5M
Cap. Flow %
-6.11%
Top 10 Hldgs %
38.26%
Holding
152
New
9
Increased
43
Reduced
30
Closed
19

Top Sells

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$4.17M
2
RGEN icon
Repligen
RGEN
+$3.64M
3
CBRL icon
Cracker Barrel
CBRL
+$3.63M
4
BFAM icon
Bright Horizons
BFAM
+$3.59M
5
VEEV icon
Veeva Systems
VEEV
+$3.59M

Sector Composition

Rank Sector Weight
1 Technology 38.24%
2 Healthcare 12.86%
3 Communication Services 11.76%
4 Consumer Discretionary 9.54%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
101
RTX Corp
RTX
$290B
$509K 0.15%
5,965
TDOC icon
102
CALL
Teladoc Health
TDOC
$1.66B
$499K 0.15%
3,000
TDOC icon
103
PUT
Teladoc Health
TDOC
$1.66B
$499K 0.15%
3,000
ETN icon
104
Eaton
ETN
$141B
$480K 0.14%
3,238
+457
+16% +$65.9K
SDY icon
105
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$462K 0.14%
3,775
IGSB icon
106
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$425K 0.13%
7,756
ALXN
107
DELISTED
Alexion Pharmaceuticals
ALXN
$400K 0.12%
2,175
MKC icon
108
McCormick & Company Non-Voting
MKC
$14B
$391K 0.12%
4,430
MMM icon
109
3M
MMM
$91.8B
$390K 0.12%
2,350
PG icon
110
Procter & Gamble
PG
$340B
$388K 0.12%
2,878
XBI icon
111
State Street SPDR S&P Biotech ETF
XBI
$10B
$380K 0.11%
2,810
VCSH icon
112
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$378K 0.11%
4,566
-121
-3% -$10K
DKNG icon
113
DraftKings
DKNG
$12.2B
$373K 0.11%
7,148
+245
+4% +$12.9K
HDV
114
iShares Core High Dividend ETF
HDV
$14.7B
$372K 0.11%
19,250
-545
-3% -$10.6K
DGRW icon
115
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.5B
$354K 0.11%
5,927
+180
+3% +$10.6K
INTC icon
116
Intel
INTC
$413B
$319K 0.09%
5,683
+101
+2% +$5.93K
AMJ
117
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$303K 0.09%
15,413
+240
+2% +$4.47K
CQP icon
118
Cheniere Energy
CQP
$30.5B
$301K 0.09%
6,800
CARR icon
119
Carrier Global
CARR
$49.4B
$297K 0.09%
6,120
VB icon
120
Vanguard Morningstar Small-Cap ETF
VB
$78.9B
$291K 0.09%
1,292
MMP
121
DELISTED
Magellan Midstream Partners, L.P.
MMP
$288K 0.09%
5,895
BIIB icon
122
Biogen
BIIB
$30.9B
$275K 0.08%
794
ARKK icon
123
ARK Innovation ETF
ARKK
$5.59B
$271K 0.08%
2,071
IVW icon
124
iShares S&P 500 Growth ETF
IVW
$70.5B
$265K 0.08%
3,648
DRE
125
DELISTED
Duke Realty Corp.
DRE
$243K 0.07%
5,135
-45
-0.9% -$2.08K

Similar funds

Covenant Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Covenant Asset Management held 152 positions worth $336M, up 4.8% from $321M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Covenant Asset Management withdrew a net $20.5M in Q2 2021, closing 19 positions and reducing 30 holdings. Its most notable exit was SolarEdge, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Covenant Asset Management opened a new position in Yeti Holdings worth $3.41M.

  • Covenant Asset Management's largest Q2 2021 buy was Yeti Holdings: 37,137 shares worth $3.41M.
  • Covenant Asset Management added most to Regeneron Pharmaceuticals in Q2 2021, an estimated $5.47M increase.
  • Covenant Asset Management's biggest Q2 2021 reduction was Kansas City Southern, cutting an estimated $1.91M.
  • Covenant Asset Management fully exited SolarEdge in Q2 2021, selling an estimated $4.17M.
  • Covenant Asset Management's ten largest holdings make up 38% of its $336M portfolio in Q2 2021.
  • Covenant Asset Management opened 9 new positions and closed 19 in Q2 2021.
  • Covenant Asset Management's portfolio value rose 4.8% quarter-over-quarter to $336M.

Based on Covenant Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.